Brain Injury Biomarkers in the General Population

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01786460

Enrollment

800

Registered

2013-02-08

Start date

2011-01-31

Completion date

2011-09-30

Last updated

2017-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Injuries, Traumatic

Brief summary

The purpose of this study is to use an investigational assay to assess levels of putative biomarkers of traumatic brain injury (TBI) in a general population. The data will be used in a correlative analysis with data collected under a separate study of severe TBI.

Interventions

OTHERBlood draw at Days 0, 7, 14, and 21

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Yes

Inclusion criteria

* At least 18 years of age and no more than 80 years of age * Willing to undergo consent * PI believes volunteer is appropriate candidate for study

Exclusion criteria

* Participating in another clinical study that may affect the results of either study * Non-English speaking * Venipuncture not feasible * Blood donation within 1 week of screening * PI determines volunteer is not medically suitable for study participation

Design outcomes

Primary

Measure	Time frame
Assessment of the putative biomarkers for TBI markers in general population using an investigational assay	up to 21 days

Secondary

Measure	Time frame
Correlation of the putative biomarkers for TBI levels in general population to levels in patients with severe TBI	0, 14, 7, and 21 days

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026